EUVIMEDEUVIMED entdecken
Crossref

Analysing Survival Outcomes in Advanced Pancreatic Cancer: Benefit of Second and Later Line Therapy ‐ Real World Outcomes from the Australasian Purple Pancreatic Cancer Registry

Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 22-22

DOI: 10.1111/ajco.70237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Analysing Survival Outcomes in Advanced Pancreatic Cancer: Benefit of Second and Later Line Therapy ‐ Real World Outcomes from the Australasian Purple Pancreatic Cancer Registry. Asia-Pacific Journal of Clinical Oncology, 22(S6), 22-22. https://doi.org/10.1111/ajco.70237

Vancouver

Analysing Survival Outcomes in Advanced Pancreatic Cancer: Benefit of Second and Later Line Therapy ‐ Real World Outcomes from the Australasian Purple Pancreatic Cancer Registry. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):22-22. doi:10.1111/ajco.70237

BibTeX
@article{euvimed2026,
  title = {Analysing Survival Outcomes in Advanced Pancreatic Cancer: Benefit of Second and Later Line Therapy ‐ Real World Outcomes from the Australasian Purple Pancreatic Cancer Registry},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {S6},
  pages = {22--22},
  doi = {10.1111/ajco.70237}
}
Kostenlos starten →